Source: International Congress 2016 – Scientific Year in Review 2016



Rating:

Share or cite this content

Citations should be made in the following way:
Ian M. Adcock (London, United Kingdom). From the bench: promising new targets and molecules. International Congress 2016 – Scientific Year in Review 2016

Member's Comments

No comment yet.

Related content which might interest you: Targeting the arginase pathway: potential developments as new avenues for treatment Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma? Year: 2004 Bringing it all together: common pathways, emerging therapeutics and future directions Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease Year: 2014 Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Lots of promising targets and biomarkers, but how can we deliver the next generation of severe asthma trials? Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players? Year: 2019 How to disrupt malicious LC-fILD pathways: antifibrotic agents as a promising therapeutic approach Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists Year: 2021 New pathways, new targets  Source: International Congress 2017 – Lung cancer immunotherapy Year: 2017 Breathe: new features and new ways to get involved Source: Breathe 2015; 11: 247-248 Year: 2015 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Targeting mucus as a new therapeutic avenue? Source: Annual Congress 2011 - Mucus in airway diseases: bad or good partner? Year: 2011 Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19 Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020 Year: 2020 What are the targets? Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 From the bedside: upcoming new clinical strategies Source: International Congress 2016 – Scientific Year in Review 2016 Year: 2016 Fibrocytes: potential new therapeutic targets for pulmonary hypertension? Source: Eur Respir J 2010; 36: 1232-1235 Year: 2010 Proteases as tools for diagnosis and novel therapeutics Source: ERS Research Seminar 2015 Year: 2015 Genetic studies as a tool for identifying novel potential targets for treatment of COPD Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017 Year: 2017 Targeting targeted therapies: more choices and the best sequences Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 From anti-PD1/L1 inhibitors to new immunotherapies Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine Year: 2019 Genomics-based identification of targets in pathogenic bacteria for potential therapeutic use Source: Annual Congress 2004 - Novel approaches to the treatment of pneumonia Year: 2004